1. Home
  2. VIR vs GLDD Comparison

VIR vs GLDD Comparison

Compare VIR & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • GLDD
  • Stock Information
  • Founded
  • VIR 2016
  • GLDD 1890
  • Country
  • VIR United States
  • GLDD United States
  • Employees
  • VIR N/A
  • GLDD N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • GLDD Military/Government/Technical
  • Sector
  • VIR Health Care
  • GLDD Industrials
  • Exchange
  • VIR Nasdaq
  • GLDD Nasdaq
  • Market Cap
  • VIR 706.4M
  • GLDD 770.3M
  • IPO Year
  • VIR 2019
  • GLDD 2006
  • Fundamental
  • Price
  • VIR $5.65
  • GLDD $11.55
  • Analyst Decision
  • VIR Strong Buy
  • GLDD Buy
  • Analyst Count
  • VIR 8
  • GLDD 1
  • Target Price
  • VIR $30.25
  • GLDD $14.00
  • AVG Volume (30 Days)
  • VIR 1.2M
  • GLDD 450.7K
  • Earning Date
  • VIR 08-04-2025
  • GLDD 08-05-2025
  • Dividend Yield
  • VIR N/A
  • GLDD N/A
  • EPS Growth
  • VIR N/A
  • GLDD 79.53
  • EPS
  • VIR N/A
  • GLDD 1.02
  • Revenue
  • VIR $20,861,000.00
  • GLDD $806,898,000.00
  • Revenue This Year
  • VIR N/A
  • GLDD $9.62
  • Revenue Next Year
  • VIR $0.62
  • GLDD $5.83
  • P/E Ratio
  • VIR N/A
  • GLDD $11.30
  • Revenue Growth
  • VIR N/A
  • GLDD 28.03
  • 52 Week Low
  • VIR $4.32
  • GLDD $7.51
  • 52 Week High
  • VIR $14.45
  • GLDD $12.89
  • Technical
  • Relative Strength Index (RSI)
  • VIR 54.74
  • GLDD 53.77
  • Support Level
  • VIR $5.31
  • GLDD $10.94
  • Resistance Level
  • VIR $5.92
  • GLDD $11.59
  • Average True Range (ATR)
  • VIR 0.30
  • GLDD 0.31
  • MACD
  • VIR 0.02
  • GLDD -0.00
  • Stochastic Oscillator
  • VIR 43.69
  • GLDD 69.61

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

Share on Social Networks: